36F79723D0101↗
Usantibiotics LLC received this contract vehicle from Nac Federal Supply Schedule (36F797), Department of Veterans Affairs: $0 obligated so far for drugs and biologicals. It runs to 2028-03-31.
Key facts · data as of Oct 26, 2026
- Recipient
- Usantibiotics LLC
- Awarding agency
- Department of Veterans Affairs
- Contracting office
- Nac Federal Supply Schedule (36F797) (36F797)
- Obligated to date
- $0
- Potential value
- $500.0K
- Ends
- 2028-03-31
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.
Cite this page: SpendQuery, Award 36F79723D0101, data as of Oct 26, 2026, https://spendquery.com/award?id=CONT_IDV_36F79723D0101_3600
Usantibiotics LLC: all federal awards · Department of Veterans Affairs: spending · Nac Federal Supply Schedule (36F797): what it buys · The follow-on: recompete brief
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Up for re-bid: ends 2028-03-31. Recompete brief → · 6505--Department of Veterans Affairs Pharmaceutical Industry Day ↗
What it is
- Product or service
- Drugs and Biologicals (PSC 6505)
- Industry
- Pharmaceutical Preparation Manufacturing (NAICS 325412)
- Contracting office
- Nac Federal Supply Schedule (36F797) (36F797)
- Competition
- Full and open competition · 999 offers received
- Pricing
- Fixed price with economic price adjustment
- How it was bought
- Contract vehicle (IDV) itself
- Solicitation
- M5-Q50A-03-R8
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Orders under this vehicle
1 order worth $30.00M (current value). The largest:
- 75A50326F80004 · $30.00M · ends 2027-05-28
Every action
14 actions since 2023-03-24. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-09-17 | P00013 | Supplemental agreement (work within scope) | $0 | LIFE CYCLE CHANGES | PL - TEMPORARY TO PERMANENT - SP - 2 NDCS |
| 2026-04-28 | P00012 | Supplemental agreement (work within scope) | $0 | 42-2A | PRODUCT ADDITION | 2 NDCS (81964-0220-28 & 81964-0220-40) |
| 2025-12-15 | P00011 | Supplemental agreement (work within scope) | $0 | 2026 PUBLIC LAW PRICING UPDATES |
| 2025-12-11 | P00010 | Supplemental agreement (work within scope) | $0 | PRODUCT ADDITION - 2 NDCS (AMOXICILLIN) |
| 2025-11-04 | P00009 | Administrative change | $0 | 3 ADMINISTRATIVE CHANGES | POC CHANGES, 3RD PARTY AGENT AUTHORIZATION & SAF REVISION |
| 2025-06-26 | P00008 | Supplemental agreement (work within scope) | $0 | PRODUCT ADDITION - 1 NDC (AMOX & CLAV) |
| 2025-06-26 | P00007 | Supplemental agreement (work within scope) | $0 | LIFE CYCLE CHANGE - TEMPORARY TO PERMANENT |
| 2024-12-10 | P00006 | Supplemental agreement (work within scope) | $0 | PUBLIC LAW 2025 PRICE(S) UPDATE |
| 2024-08-28 | P00005 | Supplemental agreement (work within scope) | $0 | ADD |
| 2024-01-10 | P00004 | Supplemental agreement (work within scope) | $0 | ADMIN |
| 2023-12-06 | P00003 | Supplemental agreement (work within scope) | $0 | PL 2024 |
| 2023-07-17 | P00002 | Supplemental agreement (work within scope) | $0 | ADMIN |
| 2023-05-13 | P00001 | Supplemental agreement (work within scope) | $0 | LIFE CYCLE CHANGE - PRICE UPDATE |
| 2023-03-24 | 0 | $0 | 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗